Procter & Gamble Company (The) $PG Shares Sold by Boston Trust Walden Corp

Boston Trust Walden Corp lessened its stake in Procter & Gamble Company (The) (NYSE:PGFree Report) by 2.4% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 410,015 shares of the company’s stock after selling 10,083 shares during the quarter. Boston Trust Walden Corp’s holdings in Procter & Gamble were worth $59,223,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in PG. Brighton Jones LLC raised its stake in Procter & Gamble by 51.5% during the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock worth $6,717,000 after acquiring an additional 13,617 shares in the last quarter. Taylor Financial Group Inc. lifted its position in Procter & Gamble by 10.6% in the first quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock valued at $493,000 after acquiring an additional 277 shares during the last quarter. Sivia Capital Partners LLC boosted its stake in Procter & Gamble by 19.8% in the second quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock valued at $979,000 after acquiring an additional 1,016 shares in the last quarter. Auxano Advisors LLC lifted its holdings in shares of Procter & Gamble by 10.8% in the 2nd quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock valued at $1,165,000 after purchasing an additional 714 shares during the last quarter. Finally, Schnieders Capital Management LLC. boosted its position in shares of Procter & Gamble by 2.8% in the 2nd quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock valued at $4,809,000 after purchasing an additional 809 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $151.30 on Friday. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $167.25. The company has a 50-day moving average price of $146.28 and a 200 day moving average price of $148.23. The company has a market cap of $352.32 billion, a P/E ratio of 22.12, a PEG ratio of 6.27 and a beta of 0.39. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.44.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Friday, April 24th. The company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.56 by $0.03. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.The business had revenue of $21.23 billion during the quarter, compared to analysts’ expectations of $21.52 billion. During the same period last year, the firm earned $1.54 EPS. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts predict that Procter & Gamble Company will post 6.9 earnings per share for the current year.

Procter & Gamble Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Friday, April 24th were issued a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a yield of 2.9%. This is an increase from Procter & Gamble’s previous quarterly dividend of $1.06. The ex-dividend date of this dividend was Friday, April 24th. Procter & Gamble’s dividend payout ratio is 63.60%.

Analyst Ratings Changes

Several research firms have commented on PG. Rothschild & Co Redburn cut their price target on Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating on the stock in a research report on Monday, April 27th. Wells Fargo & Company increased their price objective on Procter & Gamble from $158.00 to $164.00 and gave the company an “overweight” rating in a report on Monday, April 27th. Morgan Stanley cut their target price on shares of Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. BNP Paribas Exane reduced their price target on shares of Procter & Gamble from $172.00 to $165.00 and set an “outperform” rating for the company in a research report on Thursday, April 23rd. Finally, Raymond James Financial decreased their price target on shares of Procter & Gamble from $175.00 to $170.00 and set an “outperform” rating for the company in a research note on Tuesday, April 14th. Twelve analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $161.47.

View Our Latest Stock Analysis on Procter & Gamble

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

Procter & Gamble Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.